Gattefosse

Founded: 1880 • Age: 146 yrs
Produces high-quality active ingredients for the beauty and health care industries.
Annual revenue $7.4M Latest available
Total funding - Funding intelligence
Employees 21 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Gattefosse

Gattefosse is a company founded in 1880. It operates as a B2B. The company has 21 employees as of March 31, 2023. Gattefosse operates in a competitive market with competitors including Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.

  • Employees 21 as on 31 Mar, 2023
  • Sectors
    Chemicals & Materials
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Gattefosse India Private Limited
  • Date of Incorporation 18 Jul, 2007
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Chemicals & Materials → Specialty & Industrial Chemicals Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $7.4 M (USD)
    13.64
    as on Mar 31, 2023
  • Net Profit
    $2.06 M (USD)
    28.45
    as on Mar 31, 2023
  • EBITDA
    $2.71 M (USD)
    27.64
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    21

    as on Mar 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Gattefosse

Premium access

Detailed funding history for Gattefosse

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Gattefosse

Investments
Premium access

Investment portfolio details for Gattefosse

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Gattefosse

Premium access

Detailed financials for Gattefosse

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Gattefosse Comparisons

Gattefosse Primary company
Description
Produces high-quality active ingredients for the beauty and ...
Location
-
Founded Year
1880
Annual Revenue
$7.4 M (USD)
Net Profit
$2.06 M (USD)
EBITDA
$2.71 M (USD)
Employees
21
As of 2023
Premium access

Peer comparison for Gattefosse

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Gattefosse

Gattefosse operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharmaceutical and biotechnology company
Locked Locked Locked
Contract development, manufacturing, and analytical services for APIs are offered.
Locked Locked Locked
APIs and drug products are developed and valorized in pharmaceuticals.
Locked Locked Locked
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
Locked Locked Locked
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
Locked Locked Locked
APIs are manufactured and custom synthesis services are provided.
Premium access

Detailed competitors of Gattefosse

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Gattefosse

Premium access

Complete news archive for Gattefosse

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gattefosse

Gattefosse was founded in 1880.

As of Mar 31, 2023, the latest employee count at Gattefosse is 21.

Annual revenue of Gattefosse is $7.4M as on Mar 31, 2023.

Gattefosse produces high-quality active ingredients for the beauty and health care industries, focusing on producing manufactured goods, chemicals, pharmaceuticals and cosmetics, and active ingredients. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

Gattefosse's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available